Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.
Advertisement
The Scientist
Most Recent
Viral vectors used to carry transcription factors that de-differentiate cells into a stem-cell-like state are themselves a key factor in efficient reprogramming.
The researcher who falsely claimed to treat human patients with their own stem cells is dismissed, but insists that he did perform the procedure on one patient.
Scientists use human stem cells to show that nuclear defects may play a role in Parkinson’s disease, and suggest a way to reverse the problem.
Research purporting to cure patients with heart disease using induced pluripotent stem cells may be a fraud.
Arlen Specter, a long-serving senator and outspoken advocate for biomedical research, has passed away at the age of 82.
Scientists fighting the federal funding of human embryonic stem cell research bring their case before the country’s highest court.
In a Phase I trial, researchers show that neural stem cells transplanted into humans can differentiate and begin producing myelin.
John B. Gurdon and Shinya Yamanaka win this year’s Nobel Prize in Medicine for learning how to reboot cellular development.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
